|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
1998-1-8
|
|
pubmed:abstractText |
Hereditary hemochromatosis (HH) is a common autosomal recessive disease associated with loss of regulation of dietary iron absorption and excessive iron deposition in major organs of the body. Recently, a candidate gene for HH (also called HFE) was identified that encodes a novel MHC class I-like protein. Most patients with HH are homozygous for the same mutation in the HFE gene, resulting in a C282Y change in the HFE protein. Studies in cultured cells show that the C282Y mutation abrogates the binding of the recombinant HFE protein to beta2-microglobulin (beta2M) and disrupts its transport to the cell surface. The HFE protein was shown by immunohistochemistry to be expressed in certain epithelial cells throughout the human alimentary tract and to have a unique localization in the cryptal cells of small intestine, where signals to regulate iron absorption are received from the body. In the studies presented here, we demonstrate by immunohistochemistry that the HFE protein is expressed in human placenta in the apical plasma membrane of the syncytiotrophoblasts, where the transferrin-bound iron is normally transported to the fetus via receptor-mediated endocytosis. Western blot analyses show that the HFE protein is associated with beta2M in placental membranes. Unexpectedly, the transferrin receptor was also found to be associated with the HFE protein/beta2M complex. These studies place the normal HFE protein at the site of contact with the maternal circulation where its association with transferrin receptor raises the possibility that the HFE protein plays some role in determining maternal/fetal iron homeostasis. These findings also raise the question of whether mutations in the HFE gene can disrupt this association and thereby contribute to some forms of neonatal iron overload.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-1530991,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-2051996,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-2159321,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-2227617,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-2988598,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-3307444,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-3661127,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-4003478,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-503142,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-5432063,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-7175808,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-7710096,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-7939784,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-8071088,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-8696333,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-8766556,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-8896549,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-8896550,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-8931958,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-9038104,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-9054933,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-9106528,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-9122230,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9371823-9162021
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0027-8424
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
25
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
13198-202
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9371823-Chromatography, Affinity,
pubmed-meshheading:9371823-Female,
pubmed-meshheading:9371823-HLA Antigens,
pubmed-meshheading:9371823-Hemochromatosis,
pubmed-meshheading:9371823-Histocompatibility Antigens Class I,
pubmed-meshheading:9371823-Humans,
pubmed-meshheading:9371823-Immunohistochemistry,
pubmed-meshheading:9371823-Membrane Proteins,
pubmed-meshheading:9371823-Placenta,
pubmed-meshheading:9371823-Precipitin Tests,
pubmed-meshheading:9371823-Pregnancy,
pubmed-meshheading:9371823-Protein Binding,
pubmed-meshheading:9371823-Receptors, Transferrin,
pubmed-meshheading:9371823-beta 2-Microglobulin
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis.
|
|
pubmed:affiliation |
The Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, MO 63104, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
